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Purpose: Retrorsine selectively inhibits hepatocyte proliferation and following liver injury evokes small
hepatocyte-like progenitor cells. The aim of this study is to find out whether endogenous extrahepatic cells
contribute to small hepatocyte-like progenitor cells after retrorsine treatment.
Methods: Wild-type Lewis rat liver exposed to retrorsine was transplanted into GFP transgenic Lewis rat. GFP
positive, albumin-producing polygonal cells were expected as reciepient-derived hepatocyte-like cells.
Results: Four weeks after transplantation of 50% volume of retrorsine-pretreated liver, the rate of GFP positive
hepatocyte-like cells was 0.02365%. Majority of these cells resided as single cells and their cell size was significantly
larger than that of normal hepatocytes (mean cell size; 799.4 um2 vs. 451.3 um2, p<0.0001). At eight weeks, clusters
of GFP positive small-size albumin-producing cells appeared and occupied 0.00759% of hepatocytes. The
morphology of these cells was similar to that of small hepatocyte-like progenitor cells, 12.5% of them were Ki67
positive, majority of them were negative for CYP1A2 staining, and some clusters contained larger cells indicating
further maturation.
Conclusion: Endogenous extrahepatic cells can form a cluster of small cells resembling small hepatocyte-like
progenitor cells in a transplanted retrorsine-pretreated liver. The contribution of extrahepatic cells to liver mass
maintenance is quite low and its importance is unclear.
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Under normal condition, liver regeneration is completed
through mitosis of mature hepatocytes. When prolifera-
tion of hepatocytes is selectively inhibited by retrorsine
treatment, albumin-producing small cells termed small
hepatocyte-like progenitor cells (SHPCs) arise in response
to liver injuries (Gordon et al. 2000a, b, Vig et al. 2006,
Serra et al. 2012). SHPCs form a nodule without a capsule
as a result of expansive proliferation, and restore the liver* Correspondence: hmaeda@kochi-u.ac.jp; zsun2@jhmi.edu
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in any medium, provided the original work is pmass. In terms of the cellular origin of SHPCs, several stud-
ies did not conclusively determine whether SHPCs were
originated from hepatic oval cells (Vig et al. 2006, Chen
et al. 2013) or mature/maturing hepatocytes (Gordon et al.
2000a, b, Ichinohe et al. 2012). However, the involvement
of bone marrow cells to the formation of nodule of SHPCs
is considered less likely (Vig et al. 2006).
In order to study the contribution of bone marrow
(BM) stem cells to hepatocytes, BM transplantation
models have been often used. However, there is a criticism
that procedure-related cell injuries might alter the kinetics
of stem cells. In the current study, therefore, we used liver
transplantation (LT) model (Tomiyama et al. 2007) instead
of bone marrow transplantation model to study then Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Green fluorescence protein (GFP) transgenic Lewis rats
were obtained from the national Institute of health (NIH)-
funded Rat Resource and Research Center, University of
Missouri, Columbia, MO. Male wild type Lewis rats were
purchased from Harlan Sprague-Dawley (Indianapolis, IN).
Animals were maintained in the specific pathogen-free
facility of the Johns Hopkins Medical Institutions and
were cared for according to NIH guidelines and under
a protocol approved by the Johns Hopkins University
Animal Care Committee. Male rats weighting 200-225 g
(approximately 8-10 weeks old) received intraperitoneal
administration of retrorsine. Male rats weighting 230-280 g
were used for liver transplantation.
Liver transplantation (LT)
In order to minimize variation, H. Maeda performed LT
exclusively. LT was performed using cuff technique with
minor modifications (Kamada and Calne 1979, Tomiyama
et al. 2007). A donor liver was perfused with cold saline
containing 20 units of heparin. For transplantation of a
reduced size (50%) liver, left lobe, the left side of right
lobe and caudate lobe were resected immediately before
saline perfusion. The duration of anhepatic phase, from
clamp of portal vein to unclamping of infrahepatic inferior
vena cava, was between 15 and 19 minutes. After surgery,
all rats were kept individually for at least one month. In
the case of death or severe jaundice judged by the color of
urine and palm, the rats were excluded from the experi-
ment and additional transplantations were performed to
replenish the lost. Severe jaundice was mainly caused by
bilestone in common bile duct.
Experimental design and retrorsine pretreatment
LT was performed under four different conditions (Figure 1):
Group 1, a whole liver from wild-type Lewis rat was
transplanted into GFP transgenic Lewis recipient; Group 2,
a reduced size (50%) liver from wild-type Lewis rat was
transplanted into GFP transgenic Lewis recipient; Group 3,
a whole liver from retrorsine pretreated wild-type Lewis rat
was transplanted into GFP transgeneic Lewis recipient;
Group 4, a reduced size liver (50%) from retrorsine
pretreated wild-type Lewis rat was transplanted into
GFP transgenic Lewis recipient. Donor rats of Group 3
and 4 received 35 mg/kg of retrorsine (Sigma-Aldrich,
St. Louis, MO) intraperitonially twice two weeks apart.
Retorsine pretreated liver was harvested two weeks afterthe second retrorsine injection. Animals were sacrificed at
four or eight weeks after transplantation.
Definition of hepatocyte-like cell of extrahepatic cell origin
A hepatocyte-like cell derived from extrahepatic sources
was defined as a large polygonal cell which resides in a
hepatic cord, expresses GFP in both nucleus and cyto-
plasm identical to a hepatocyte in GFP transgenic rat
(Additional file 1: Figure S1) and exhibits positive staining
with anti-albumin antibody (Tomiyama et al. 2007).
Sample preparation and calculation of the contribution rate
One or two month after transplantation, the rats were
sacrificed by exsanguination under general anesthesia.
The liver was slowly perfused with 50 ml PBS via portal
vein, and followed by 50 ml 2% paraformalin. Excised
liver was cut into small pieces (5-10 cubic mm) and fur-
ther fixed with 2% paraformalin for one hour at room
temperature in dark. Liver tissues were then incubated
in 30% sucrose overnight at four degrees. Two to four
pieces of liver samples were randomly embedded in O.C.T.
Compound (Sakura Finetek USA, Torrance, CA) and
stored in a -80 degree freezer.
To quantitatively analyze the recipient-derived hepatocyte-
like cells, pictures of the tissue sections were taken with
reference (1 square cm) and then areas of the sections
were measured by using Adobe Photoshop CS3 (Adobe
systems, San Jose, CA). Then, the number of hepatocytes
within 0.16 mm2 from 10 microscopic random fields was
examined. Subsequently, 144 cells in the liver without
retrorsine treatment and 109 cells in retrorsine-pretreated
liver were counted on average. After screening the whole
specimen, the rate of extrahepatic cell contribution
was calculated. In order to avoid counting the same
cell redundantly, the sections were prepared at least
36 μm apart from each other.
Immunoflourescence
Six μm tissue sections were incubated with 1% SDS
(detergent) in PBS for 12 minutes. For albumin staining, sec-
tions were incubated with sheep anti-rat albumin antibody
(1:800 dilution, BETHYL laboratory Inc, Montgomery, TX)
for 30 min, followed by Cy3-conjugated donkey anti-sheep
IgG antibody (1:400 dilution, Jackson immunoreserch
laboratories, west Grove, PA) for 30 min. For Ki67 staining,
sections were incubated with mouse anti-human Ki67
antibody (1:50 dilution, BD Pharmingen, San Jose, CA)
for 60 min, followed by Cy3-conjugated donkey anti-mouse
IgG antibody (1:100 dilution, Jackson immunoreserch
laboratories) for 30 min. For CYP1A2 staining, sections
were incubated with mouse anti-rat CYP1A2 (1:100 dilution,
Abcam, Cambridge, MA) antibody for 60 min, followed
by Cy3-conjugated donkey anti-mouse IgG antibody
for 30 min. Nuclear staining was performed with DAPI
Figure 1 Time line of the experiment. Group 1 and 2 received whole liver or reduced size (50%) LT (white arrow head) and were
sacrificed at 8 weeks (black arrow head). In Group 3 and 4, the donor rats received 35 mg/kg of retrorsine (black arrow) twice two weeks
apart. Group 3 received whole LT, while Group 4 received 50% LT. Half of them (n=3) were sacrificed at four weeks and rest of them were
sacrificed at eight weeks.
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blocking was performed with 10% donkey serum.Immunohistochemistry
The tissue sections were incubated with 1% SDS in
PBS for 12 minutes. Then, they were incubated in 1%
H2O2 in PBST for 25 min. After avidin, biotin block
(Avidin blocking system; DAKO), sections were incubation
with biotin conjugated anti-GFP antibody (Abcam) for
one hour. Tissue sections were then incubated with AB
complex (VECTASTAIN ABC kit; Vector, Burlingame, CA)
for 30 min according to the manufacture instruction and
reacted with DAB (Liquid DAB+ Substrate Chromogen
System; DAKO). Counterstaining was performed by using
Haematoxylin for 20 seconds. After each step, sections were
adequately rinsed with PBST. When the same specimen
was stained for GFP following albumin observation, incuba-
tion with 1% SDS was not performed again.
To evaluate proliferation of oval cells after LT, OV-6
expression was studied on immunohistochemistry staining.
Sections were incubated in 1% H2O2 in PBST for 25 min.
Then, non-specific staining was reduced by incubation
with 5% donkey serum for 10 min. After avidin biotin
block, sections were incubated with anti-OV-6 antibody
(1:50 dilution, Santa Cruz Biotechnology, Dallas, TX) for
one hour followed by biotin-conjugated anti-mouse anti-
body (1:100 dilution, Jackson immuneresearch laboratories)
for 30 min. The signal was amplified with AB complex and
detected with DAB.Statistical analysis
Statistical analysis and graphic depiction was performed by
using KaleidaGraph version 4.0 (synergy software, Reading,
PA) or Microsoft Office Excel (Microsoft, Redmond, WA).
A p- value of less than 0.05 was considered statistically sig-
nificant. The method of analysis is described individually.Results
Mortality and exclusion of rats
Most recipients survived (19 out of 20, 95%) irrespective
of whether rats received retorsine-pretreated or untreated
livers. One recipient rat died and one rat was excluded
due to severe jaundice. Additional LT was uneventfully
performed.GFP positive hepatocyte-like cells in livers without
retrorsine treatment (Group 1 & 2)
For each individual, eight to 12 separate sections were
examined. GFP positive hepatocyte-like cells contribute to
approximately 0.00186% of total hepatocytes at eight weeks
after whole liver transplantation (Group 1) (Table 1 and
Figure 2A-E). Roughly, if 1 cm2 of specimen is screened,
one or two GFP positive hepatocyte-like cells are found.
The localization of these cells seems to be haphazard and
neglecting the acinar zone. Among 56 randomly examined
GFP positive hepatocyte-like cells, 10 hepatocytes (17.9%)
were located adjacent to each other (Figure 2F). Reduced
sized liver transplantation (Group 2) did not augment
the contribution rate of GFP positive hepatocyte-like cells.
Neither nodule of SHPCs nor clusters of GFP positive cells
were identified.Histological changes after transplantation of
retrorsine-pretreated liver
A few small nodules of SHPCs and a few abnormally
enlarged hepatocytes (megalocytes) were observed four
weeks after retrorsine-pretreated whole liver transplantion
(Group 3). However, the number of nodules of SHPCs
increased and larger nodules of SHPCs were observed
at eight weeks after transplantation (Figure 3A&B and
Additional file 1: Figure S2). In contrast, the SHPCs and
megalocytes were abundant in reduced sized retrorsine
treated livers (Group 4) at four weeks after transplantation.
These findings resembled histological changes in the liver
Table 1 Rate of extrahepatic cell contribution to hepatocytes after retrorsine-pretreated liver transplantation
Screened hepatocytes (cells) GFP positive hepatocyte-like cells (%) Cluster of cells (%)
Group 1 (Whole LT) 8 weeks
No.1 1326229 0.00203 -
No.2 702764 0.00192 -
No.3 1229473 0.00154 -
Average 0.00186 -
Group 2 (50% LT) 8 weeks
No.1 941860 0.00180 -
No.2 1247150 0.00208 -
No.3 2397670 0.00125 -
Average 0.00171 -
Group 3 (whole LT & retrorsine) 4 weeks
No.1 741873 0.00471 -
No.2 640212 0.02218 -
No.3 1081604 0.00320 -
Average 0.01004 -
Group 3 (whole LT & retrorsine) 8 weeks
No.1 67241 0.04462 0.00357
No.2 400033 0.00475 0.00650
No.3 495994 0.00323 0.01270
average 0.01753 0.00759
Group 4 (50% LT & retrorsine) 4 weeks
No.1 404164 0.02944 -
No.2 311261 0.01799 -
No.3 603841 0.02351 -
Average 0.02365
Group 4 (50% LT & retrorsine) 8 weeks
No.1 529228 0.00747 0.00624
No.2 438945 0.01618 -
No.3 797411 0.00778 0.00278
Average 0.01056 0.00300
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tomy (Gordon et al. 2000a, b). The nodules of SHPCs re-
placed majority of the liver tissues and megalocytes were
observed less frequently at eight weeks in Group 4.
GFP positive hepatocyte-like cells and cluster of small
cells in livers with retrorsine-pretreatment (Group 3 & 4)
In Group 3, the rate of GFP positive hepatocyte-like cells
was 0.01004% at four weeks and 0.01753% at eight weeks
(Table 1), and 4.5% of these cells resided adjacent to each
other. Some of these cells were abnormally large and
irregular in shape (Figure 3C&D). Notably, clusters of
GFP positive small cells (> three cells) were observed in
Group 3, which occupied 0.00759% of total hepatocytes at
eight weeks after transplantation (Figure 4A-F). The size of
cells and each cell’s nucleus was mostly homogenous withinthe cluster (Figure 4E), and it varied among clusters.
Occasionally, a cluster contained different sizes of GFP
positive hepatocyte-like cells within it (Figure 4F). Immuno-
fluorescence staining demonstrated that these GFP positive
small cells were albumin producing cells (Figure 4C).
And some of these cells were positive for Ki67 staining
(Figure 4F&G). However, the majority of them were nega-
tive for P450 (CYP1A2) and rest of them were very weakly
positive (Figure 5G-L), which was contrast to transplanted
hepatocytes (Additional file 1: Figure S3). Thus, these GFP
positive small cells closely resemble SHPCs and we called
them as GFP positive SHPCs-like cells.
The rate of GFP positive hepatocyte-like cells in retrorsine
treated small livers (Group 4) was 0.02365% at four weeks.
Majority of GFP positive hepatocyte-like cells were abnor-
mally large as observed in Group 3. However, the rate GFP
Figure 2 GFP positive hepatocyte-like cells. GFP positive hepatocyte-like cells in Group 1 is shown. (A) Albumin staining. (B) GFP expression.
(C) Merged image. (D) IHC staining for GFP. (E) Higher magnification of D. (F) Double cells. Bar is 50 um.
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(0.01056% vs. 0.02365%, p<0.05, Mann-Whitney U test)
as the size of nodule of GFP negative SHPCs enlarged.
Clusters of GFP positive cells were also identified in tissue
sections at 8 weeks in Group 4, which rate was also very
low (Additional file 1: Table S1).
Size of GFP positive hepatocyte-like cells and SHPCs-like cells
The sizes of hepatocytes were measured for quantitative
analysis (Figure 6). The detail of the methods and results
of statistical analysis are described in Additional file 1:
Information S1 and Table S2. Briefly, cells were classified
into six categories: 1, hepatocytes in normal livers (control);
2, GFP negative hepatocytes in Group 1; 3, GFP positivehepatocyte-like cells in Group 1; 4, GFP positive
hepatocyte-like cells in Group 4; 5, GFP negative SHPCs in
the liver graft; 6, GFP positive SHPCs-like cells. The cells
size was compared by using non-repeated ANOVA and
post-hoc test (Scheffe).
After transplantation, the size of GFP negative hepa-
tocytes was widely distributed and slightly larger than
that of hepatocytes in nontransplanted normal livers
(median; 463.1 μm2 vs. 451.3 μm2, p=0.049). GFP positive
hepatocyte-like cells in the livers of Group 1 and 4 were
significantly larger than GFP negative hepatocytes in
Group 1 and control (median; 709.5 μm2 and 726.3 μm2
versus 463.1 μm2 and 451.3 μm2, p<0.0001), although the
some of these cells were similar to normal hepatocytes in
Figure 3 Pathological features of retrorsine-pretreated liver after LT and GFP positive hepatocyte-like cells. (A) and (B) Eight weeks after
whole transplantation of retrorsine-pretreated liver shows nodules of SHPCs. (A) Hematoxylin Eosin staining after 10% formalin fixation. (B) GFP
staining and Hematoxylin staining after 2% paraformalin fixation. The cell structure is well preserved. The surrounding hepatocytes are larger than
normal. (C) and (D) Four weeks after transplantation of 50% retrorsine pretreated liver shows abnormally large hepatocytes and SHPCs. (C) IHC
staining for GFP. Observation of serial section confirmed the fragment of GFP positive cell is a part of the main cell. Lower part of the picture is
SHPCs. (D) Higher magnification of (C). Bar is 50 um.
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to GFP negative SHPCs (351.6 and 390.3 μm2, respectively),
and both of these cells were smaller than GFP negative
hepatocytes in Group 1 (p<0.01).Proliferation of GFP positive SHPC-like cells
To find whether GFP positive SHPCs-like cells were under-
going proliferation, liver tissue sections were stained with
Ki67 antibody (Additional file 1: Information S2). In normal
liver (without liver transplantation), approximately 0.85% of
hepatocytes were positive for Ki67 (Table 2). There was no
difference in Ki67 expression between GFP negative hepa-
tocytes and GFP positive hepatocyte-like cells in Group 1
(4.70% vs. 4.55%, p=0.81, Pearson’s chi-square test). Not-
ably, the rate of Ki67 positive cells in small nodules of GFP
negative SHPCs (less than 50 cells on examined pane) was
high (9.32%) while the rate was low (4.11%) in larger
nodules (more than 100 hepatocytes on examined plane),
probably reflecting the maturation of composing hepa-
tocytes. GFP positive SHPC-like cells showed high rate
of Ki67 positive cells (12.5%).Oval cell proliferation after LT
Eight weeks after transplantation of the liver without
retrorsine-pretreatment (Group 1 or 2), the periportal area
showed a small amount of OV-6 positive cholangiocytes
and OV-6 negative infiltrating cells (Figure 7B). Four weeks
after LT of 50% volume of retrorsine-pretreated liver
(Group 4), the specimen showed strong ductular reaction
(Figure 7C), which subsided by eight weeks (Figure 7D).
Contrarily, the ductular reaction and emergence of inter-
mediate hepatobiliary cells persisted at least eight weeks
after whole LT of retrorsine-pretreated liver (Group 3)
(Figure 7E&F).Discussion
Hepatic injury causes occurrence of SHPCs in retrorsine-
treated liver, and they gradually restore the loss of hepato-
cytes or replace the injured hepatocytes (Serra et al. 2012,
Gordon et al. 2000a, b, Vig et al. 2006). Although SHPCs
have some of phenotype makers in common with oval cells
or mature hepatocytes (Gordon et al. 2000a, b), the most
intrinsic features of SHPCs are their small size, albumin
Figure 4 Clusters of GFP positive SHPCs-like cells in retrorsine-pretreated liver. Eight weeks after transplantation of retrorsine-pretreated
liver, clusters of GFP positive cells are observed. These cells were not observed in Group 1 or 2. (A) Albumin staining. (B) GFP. (C) Merged image.
(D) IHC staining of GFP for the same section. Nodule contains approximately 20 GFP positive cells in this plain. Surrounding hepatocytes are
slightly larger than normal size hepatocytes. (E) Larger size nodule contains approximately 40 GFP positive cells. The nodule is beginning to
compress the surrounding hepatocytes. Right upper part is nodule of GFP negative SHPCs. Note that the magnification is lower than D or F. (F) A
cluster containing several sizes of GFP positive cells is also observed at lower frequency. A cluster of GFP positive SHPCs-like cells shows Ki67
positive staining. (G) Merged image of GFP (green) and Ki67 (red). (H) Higher magnification of same field with nucleus staining (blue). The Cluster
of cells is surrounded by megalocytic hepatocytes with larger nucleus. Bar is 50 um.
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Figure 5 Expression of CYP1A2 in retrorsine pretreated liver eight weeks after transplantation. (Left column) CYP1A2. (Middle column)
GFP. (Right column) Merged image of CYP1A2, GFP and nucleus (blue). (A)-(C) Nodule of SHPCs (upper side of the picture) is expansively
growing and compressing surrounding hepatocytes which have CYP1A2 expression. (D)-(F) Large hepatocyte-like cells (megalocyte) are weekly
positive for CYP1A2. (G)-(I) Majority of the GFP positive SHPCs-like cells lack in CYP1A2 expression. Some of them express CYP1A2 weekly.
(J)-(L) Small cluster of GFP positive small cells are surrounded by CYP1A2 positive larger cells. Nodule of SHPCs is also observed (lower part of the
picture). (M)-(O) 14 days after hepatocyte transplantation in retrorsine-pretreated hepatectomized liver. Formation of nodules by transplanted
hepatocytes (GFP positive) and endogeneous SHPCs (GFP negative) are observed. Majorities of transplanted hepatocytes are CYP1A2 positive,
opposite of GFP positive SHPCs-like cells.
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expression of some CYP isozymes at immature stage.
Because retrorsine is metabolized into active forms in hep-
atic microsomes and then selectively damages hepatocytes,the lack of CYP expression might be the mechanism of
retrorsine resistance of SHPCs (Gordon et al. 2000b).
The origin of SHPCs is largely endogenous cell popula-
tion of the liver and contribution of bone marrow cells
Figure 6 Distribution of hepatocyte cell size. The cell size of five different types of cells is compared. First 100 cases were presented in dot
plot, if the measurement exceeded 100 cells. The size of GFP negative (-) hepatocyte in Group 1 is widely distributed and larger than that of
normal liver without any treatment (Cont) (p=0.049). GFP positive (+) hepatocyte-like cells in Group1 and Group 4 at 4 weeks are significantly
larger than those of the others (p<0.001). However, no significant difference was detected between GFP (+) hepatocyte-like cells from Group1
and 4 (p=0.457). GFP (+) SHPCs-like cells and GFP (-) SHPCs are smaller than GFP (-) hepatocytes in Group 1 (p<0.01). Analysis was performed by
non-repeated ANOVA with post-hoc test (Scheffe) and p<0.05 was considered significant.
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study using LT model, however, we identified the clusters
of GFP positive small cells fulfilling these characteristic
features of SHPCs for the first time. Also, GFP positive
SHPCs-like cells at eight weeks showed high rate of Ki67
positive cells and several size of nucleus, suggesting their
ability of proliferation and maturation. Besides, the
retrorsine pretreated liver showed clusters of GFP positive
hepatocytes at least more than six month after transplant-
ation, suggesting long-term survival in the transplanted
liver (data not shown). However, the biological importance
of GFP positive SHPCs-like cells is unclear due to the very







Group Control Group 1 Group 1
Post LT - 8 weeks 8 weeks
Screened cells 1315 872 66
Positive cells 11 41 3
Rate (%) 0.84 4.70 4.55Whether the contribution of extrahepatic cells to
hepatic parenchymal cells is accomplished through
transdifferentiation or cell fusion is also frequently debated.
This could not be directly addressed due to the rarity of
GFP positive hepatocyte-like cells and therefore the cell
sizes were focused in the current study. As a result, the size
of GFP positive hepatocyte-like cells was found larger
than surrounding GFP negative hepatocytes in the liver
of Group 1. Because GFP positive hepatocyte-like cells
occasionally resided adjacent to each other or showed Ki67
positive staining, some of them are under the process of cell
proliferation. However, the rate of Ki67 positive cells among







Group 4 Group 4 Group 4




Figure 7 Evaluation of ductular reaction after LT. (A), (B), (E)&(F) OV-6 immunohistochemistry staining. (C)&(D) H.E. staining. (A) Normal control
without liver transplantation. Only cholangiocytes are positive for OV-6 staining. (B) Eight weeks after liver transplantation without retrorsine treatment
(Group 1), oval cell reaction is not observed. (C) Retrorsine-pretreated liver four weeks after whole transplantation (Group 3). The liver section shows
vigorous proliferation of bile ducts and small cells with oval nucleus (black arrow). Small hepatocyte-like cells (white arrow) are scarcely observed and
formation of nodules is not clear in this field. (D) Retrorsine-pretreated liver eight weeks after partial liver transplantation (Group 4). Nodules of SHPCs
(margined with white arrow) or relatively mature hepatocytes are large and abundant. The portal area is similar to Group 1 or 2, suggesting the
completion of live regeneration. (E)&(F) Eight weeks after whole transplantation of retrorsine-pretreated liver (Group 3). The oval cell reaction persists
at least until eight weeks when the whole liver with retrorsine-pretreatment is transplanted. Both intermediate hepatic cells (black arrow) and nodules
of SHPCs are observed.
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positive hepatocyte-like cells in retrorsine-pretreated liver
showed abnormally large size and irregular shape. These
results may imply that GFP positive hepatocyte-like cell is
formed by cell fusion rather than transdifferentiation of
extrahepatic cells into hepatocytes. Furthermore, we also
performed LT transplantation of opposite direction, fromGFP transgenic rat liver to a wild type rat. In this model,
no GFP negative megalocytic hepatocyte was found at four
weeks (Additional file 1: Figure S3). However, this approach
didn’t provide a clue about the pathway of contribution of
extrahepatic cells to SHPCs-like cells.
In this experiment, LT model was used instead of
BM transplantation in order to find the contribution of
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on bone marrow is limited in LT model because damage on
BM cells is short periods of congestion in rear part of the
body during the clamping of IVC. This may explain why the
current study showed GFP positive small cells resembling
SHPCs and a previous experiment did not identified similar
cell population (Vig et al. 2006). However, LT model also
has unique problems. First, it cannot specify the origin of
the extrahepatic cells. Being consistent with majority of pub-
lished data, we found a very few GFP positive hepatocyte-
like cells in wild-type livers after BM transplantation from
GFP transgenic rats (data not shown). Therefore, BM is one
of the most likely sources of hepatocytes in LT models, too.
However, other organs possess resident stem progenitor
cells, and these cells are potentially mobilized into peripheral
circulation and take part in organ repair (Kolonin 2012).
Compared to BM, from which BM cells are continuously
released into peripheral blood, the contribution of stem
cells from other organs under physiological condition
should be minimal. However, balance of contribution may
change under pathological condition (Kolonin 2012), which
study has only just begun. Second, liver transplantation
itself causes acute and chronic liver injuries. Abnormalities
in bile duct system due to lack of arterial reconstruction
(Hori et al. 2012) and the use of stent for bile duct recon-
struction also caused intra- and/or extra hepatic cholelithia-
sis almost in all cases in this study. Probably, these factors
caused differences in cell sizes and Ki67 expression of en-
dogenous hepatocytes between control (no transplantation)
and LT groups. Chronic liver injury due to cholelithiasis
also seems to be the reason of gradual and persistent emer-
gence of SHPCs and continuous oval cell reaction after
whole transplantation of retrorsine-pretreated liver.
The limitation of our study is that GFP is the only
marker used to detect the extrahepatic cells. Because of
the very low rate of extrahepatic cell contribution, detection
of X or Y chromosome as a marker of extrahepatic cells
after sex-mismatch transplantation seems difficult. Also,
due to the usage of paraformalin for better preservation
of GFP signals, further characterization of GFP positive
SHPCs-like cells by detecting the weaker cell markers
was difficult. Despite limitations, the current study found
that extrahepatic cells can form a cluster of small cells
which closely resemble SHPCs in retrorsine-pretreated
transplanted rat liver. The rate of contribution is quite
low and further study is necessary to illuminate its bio-
logical importance.Additional file
Additional file 1: Figure S1. Liver of GFP transgenic rat. Figure S2. The
SHPCs after transplantation of retrorsine-pretreated liver. Figure S3.
Hepatocyte transplantation after retrorsine-treatment. Table S1. Cluster of
GFP positive cells that resemble SHPCs. Information S1. Measurement ofcell size. Table S2. Non-repeated ANOVA and post-hoc test for the
comparison of cell size. Information S2. Rate of Ki67 positive cells.
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